FDA approves generic valsartan amid drug shortage

The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood pressure medicine valsartan, as the agency looks to ease shortages triggered by several manufacturers recalling the drug over possible cancer risk.

from Reuters: Health News https://ift.tt/2HfkzXt
via IFTTT